You are here: Industry Insights > Clinical Trial

News List

Bayer's Ph III clinical trial of Nifurtimox in pediatric patients with Chagas Disease meets primary endpoint biospectrumasia
March 15, 2019
Chagas is an infectious disease caused by a parasite (Trypanosoma cruzi) and transmitted to humans via the feces of triatomines, also known as kissing bugs.
Rocket Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Trial of RP-L102 in the U.S. firstwordpharma
March 13, 2019
Rocket Pharmaceuticals, Inc.(NASDAQ:RCKT) ("Rocket"), a leading U.S.-based multi-platform gene therapy company, today announces that the first patient has been dosed in the open-label, Phase 1 clinical trial of RP-L102, the Company's lentiviral vector (LV
Almac Group Launches Almac One contractpharma
March 07, 2019
Clinical trial supply solution aims to provide a responsive end-to-end process that enhances visibility and accuracy throughout a clinical study
CRISPR gene editing stocks fall after Editas CEO resigns pharmaphorum
January 24, 2019
Shares in firms developing therapies based on CRISPR gene editing technology have fallen after the resignation of the CEO of one of the leading biotechs in the field, Editas.
Clinical trial to develop cancer diagnosing breath test pharmatimes
January 08, 2019
Cancer Research UK has announced that researchers have launched a clinical trial to develop a breath test that could help to find cancer early, when treatment is more likely to be effective.
Clinical trial to develop breath test for cancer launched europeanpharmaceuticalreview
January 04, 2019
A clinical trial to analyse breath for volatile organic compounds to detect different types of cancer has been launched by Cancer Research UK…
FDA Grants Mustang Bio ODD contractpharma
December 21, 2018
The U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to Mustang Bio’s MB-102 (CD123 CAR T) for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN)
FDA releases Guidance for Industry on Clinical Trial Endpoints for the Approval of Cancer Drugs and Biologics americanpharmaceuticalreview
December 20, 2018
FDA is announcing the availability of a revised guidance for industry entitled “Clinical Trial Endpoints for the Approval of Cancer Drugs and Biologics.”......
Buprenorphine-Naloxone Cost-Effective for Opioid Use Disorder drugs
December 18, 2018
Buprenorphine-naloxone is cost-effective compared with extended-release naltrexone for treating opioid use disorder, according to a study published online Dec. 18 in the Annals of Internal Medicine.....
Neurocrine slumps as Tourette’s drug fails clinical trial pharmaphorum
December 14, 2018
Shares in Neurocrine Biosciences slumped by as much as a fifth after a much-anticipated trial in Tourette’s syndrome missed the mark.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 28 29 Next page